GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alector Inc (STU:0Z2) » Definitions » Sale Of Investment

Alector (STU:0Z2) Sale Of Investment : €583.45 Mil (TTM As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Alector Sale Of Investment?

Alector's sale of investment for the three months ended in Mar. 2024 was €170.42 Mil. It means Alector gained €170.42 Mil from selling investments. Alector's sale of investment for the trailing twelve months (TTM) ended in Mar. 2024 was €583.45 Mil.

Compared with last quarter (€142.64 Mil in Dec. 2023 ), Alector gained more money from selling investments in Mar. 2024 (€170.42 Mil).


Alector Sale Of Investment Historical Data

The historical data trend for Alector's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alector Sale Of Investment Chart

Alector Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Investment
Get a 7-Day Free Trial 446.40 334.38 262.83 379.49 601.58

Alector Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 196.14 117.81 152.58 142.64 170.42

Alector Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €583.45 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alector Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Alector's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Alector (STU:0Z2) Business Description

Traded in Other Exchanges
Address
131 Oyster Point Boulevard, Suite 600, South San Francisco, CA, USA, 94080
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.

Alector (STU:0Z2) Headlines

No Headlines